ATG10-AS1

Across TCGA pan-cancer cohorts, ATG10-AS1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ATG10-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where ATG10-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ATG10-AS1 is over-expressed in tumor.

BRCA and LUSC are the cancer types where ATG10-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ATG10-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.120	.043	2	view →
LUSC	Male	All	+0.011	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ATG10-AS1–BRCA

Open the BRCA breakdown →